KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $54.8 million.

  • Petmed Express' Total Current Liabilities rose 1419.96% to $54.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $54.8 million, marking a year-over-year increase of 1419.96%. This contributed to the annual value of $62.8 million for FY2025, which is 1301.31% down from last year.
  • Latest data reveals that Petmed Express reported Total Current Liabilities of $54.8 million as of Q4 2025, which was up 1419.96% from $56.7 million recorded in Q3 2025.
  • In the past 5 years, Petmed Express' Total Current Liabilities ranged from a high of $78.8 million in Q2 2023 and a low of $16.3 million during Q3 2021
  • Its 5-year average for Total Current Liabilities is $50.7 million, with a median of $55.5 million in 2022.
  • In the last 5 years, Petmed Express' Total Current Liabilities skyrocketed by 22959.37% in 2023 and then tumbled by 3375.83% in 2024.
  • Petmed Express' Total Current Liabilities (Quarter) stood at $26.3 million in 2021, then soared by 108.43% to $54.7 million in 2022, then soared by 32.25% to $72.4 million in 2023, then tumbled by 33.76% to $48.0 million in 2024, then increased by 14.2% to $54.8 million in 2025.
  • Its Total Current Liabilities stands at $54.8 million for Q4 2025, versus $56.7 million for Q3 2025 and $57.6 million for Q2 2025.